Despite the substantial global burden of human fungal infections, there are no approved
fungal vaccines to protect at risk individuals. Here, we review the progress that has been …

Fungal infections include a wide range of opportunistic and invasive diseases. Two of four
major fatal diseases in patients with human immunodeficiency virus (HIV) infection are …

Coccidioidomycosis is the endemic mycosis caused by the fungal pathogens Coccidioides
immitis and C. posadasii. This review is a summary of the recent advances that have been …

The dramatic increase in fungal diseases in recent years can be attributed to the increased
aggressiveness of medical therapy and other human activities. Immunosuppressed patients …

The numbers of reported cases of coccidioidomycosis in Arizona and California have risen
dramatically over the past decade, with a 97.8% and 91.1% increase in incidence rates from …

Coccidioidomycosis is a human fungal disease cause by inhalation of aerosol spores
produced by Coccidioides posadasii or Coccidioides immitis. This disease is a common …

Coccidioides immitis and posadasii are closely related fungal species that cause
coccidioidomycosis. These dimorphic organisms cause disease in immunocompetent as …

Coccidioidomycosis (Valley fever) is a fungal disease caused by the inhalation of
Coccidioides posadasii or C. immitis. This neglected disease occurs in the desert areas of …

We have previously reported that C57BL/6 mice vaccinated with a live, attenuated mutant of
Coccidioides posadasii, referred to as the ΔT vaccine, are fully protected against pulmonary …

In recent years, fungal vaccine research emanated significant findings in the field of
antifungal T-cell immunity. The generation of effector T cells is essential to combat many …